A detailed history of Lindbrook Capital, LLC transactions in Quanterix Corp stock. As of the latest transaction made, Lindbrook Capital, LLC holds 118 shares of QTRX stock, worth $1,360. This represents 0.0% of its overall portfolio holdings.

Number of Shares
118
Previous 165 28.48%
Holding current value
$1,360
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$10.92 - $16.36 $513 - $768
-47 Reduced 28.48%
118 $1,000
Q4 2023

Jan 31, 2024

SELL
$19.54 - $28.66 $156 - $229
-8 Reduced 4.62%
165 $4,000
Q3 2023

Oct 25, 2023

BUY
$21.15 - $27.96 $169 - $223
8 Added 4.85%
173 $4,000
Q1 2023

Apr 26, 2023

SELL
$10.12 - $14.91 $192 - $283
-19 Reduced 10.33%
165 $1,000
Q4 2022

Jan 24, 2023

SELL
$8.75 - $14.02 $393 - $630
-45 Reduced 19.65%
184 $0
Q3 2022

Nov 10, 2022

BUY
$7.46 - $19.28 $1,708 - $4,415
229 New
229 $3,000
Q2 2022

Aug 01, 2022

BUY
$15.06 - $30.65 $0 - $0
0 New
0 $0

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $426M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.